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Bern,
Der Dekan der Vetsuisse-Fakultät Universität Bern coli can be isolated from udders of animals suffering from a severe clinical mastitis (Hogan and Smith, 2003) . However, an infection with the gram-negative S. aureus typically results in chronic mastitis that persists lifelong (Sutra and Poutrel, 1994) .
Invading pathogens are known to induce an immune response by stimulating the innate immune system in the mammary gland. The main pathogenic component of E.
coli is lipopolysaccharide (LPS) and one of the main pathogenic components of S.
aureus is lipoteichoic acid (LTA). LPS is a part of the outer membrane in the cell wall of gram-negative bacteria (Rietschel et al., 1994) . LTA is a cell wall component in the murein capsule of gram-positive bacteria (Fischer, 1994) . Intramammary injections of LPS have been used to mimic bacterial invasion to study the mammary response to inflammation (Schmitz et al., 2004; Werner-Misof et al., 2007) . Comparable studies with intramammary infusions of LTA have also been reported (Rainard et al., 2008) .
A challenge with endotoxins allows the investigation of the mammary response to different pathogenic agents without a live bacterial infection.
E. coli and S. aureus pathogens induce different immune responses in the bovine
mammary gland (Riollet et al., 2000; Bannerman et al., 2004; Petzl et al., 2008) and in isolated cells from the mammary gland (Lee et al., 2006; Griesbeck-Zilch et al., 2008) . LPS and LTA were shown to induce different in vitro immune responses in bovine mammary epithelial cells (Strandberg et al., 2005) . However, a direct comparison of the mammary tissue with mammary cell immune response to these endotoxins has not appeared in the literature.
During a mammary gland immune response the somatic cell count (SCC) increases as a result of the immunological status of the udder and is an indicator of the infection of the bovine mammary gland (Harmon, 1994) . The intramammary infusion of LPS (Bannerman et al., 2003) or LTA (Rainard et al., 2008) elicits an immune response that produces an increase in SCC.
Another indicator of an immune response in the mammary gland is the enzyme lactate dehydrogenase (LDH). It is a ubiquitous enzyme of the glycolytic pathway that is found in all cells and is an indicator of inflammation because it is released from the cell during damage and death (Glick, 1969) . The activity of LDH increases in milk during clinical mastitis (Chagunda et al., 2006) .
Somatic cells in milk react during an infection with E. coli or S. aureus with the production of inflammatory mediators which are important to activate and maintain the immune response (Lee et al., 2006) . In addition, the mammary epithelial cells are an important source of immunological active and bactericidal substances . Some important immune factors of mammary tissue and somatic cells are tumor necrosis factor alpha (TNFα), interleukin (IL)-1β, IL-8, lactoferrin (Lf), or RANTES (regulated upon activation, normal T-cell expressed and secreted). TNFα is a rapid response mediator of inflammatory functions that increases in milk after immune stimulation with LPS (Paape et al., 2002) . The cytokine IL-1β is upregulated in milk cells during infection to initiate the immune response (Lee et al., 2006) . IL-8
and RANTES are chemokines that participate in the mastitis reaction by attracting neutrophils to the site of inflammation (Boudjellab et al., 2000; Persson Waller et al., 2003; Pareek et al., 2005) . Lactoferrin is known to have antibacterial effects. During acute mastitis, neutrophil leukocytes are another source of this protein in addition to the contribution by epithelial cells (Harmon & Newbould, 1980) . 
LDH activity and TNFα concentration in milk
The catalytic activity of LDH was detected in milk serum using the test kit LDH IFCC (Axon Lab AG, Baden, Switzerland) and quantified by COBAS MIRA (Roche Diagnostics, Switzerland) according to manufacturer's instructions.
The protein content of TNFα was determined by radioimmunoassay according to Blum et al. (2000) using a rabbit anti bovine-TNFα antibody provided by Dr. T.
Elsasser, USDA, Beltsville, USA. 
Messenger (m) RNA quantification by real-time RT-PCR

Results
Milk composition
SCC. The SCC at the beginning of the experiment from all experimental quarters (57 cows) was 4.62±0.03 log10/mL. After 3 h p.c., SCC was higher in quarters treated with 0.2μg or 1μg LPS, and 10μg LTA when compared to control quarters. (Table 1) . Control quarter SCC did not change throughout the experiment.
LDH.
The enzymatic activity of LDH in milk was 32±2 I/U in all quarters before challenge (0 h) and did not change in control quarters. In all 3 LPS treatments LDH increased at 3 h p.c.. In LTA treated quarters, LDH increase required 4h p.c.. After increasing the LDH activity stayed high in all treatments until the end of the experiment. The increase of LDH activity was dose dependent (Table 1) TNFα. TNFα concentrations in milk did not change in control quarters and in LTA treated quarters throughout the experiment (Table 1 ). In milk from LPS treated quarters TNFα concentrations started to increase 3 h p.c. dose dependently (Table   1 ). In quarters treated with 0.2 and 1 µg LPS the TNFα concentrations declined to baseline levels 12 h p.c., but 10 µg LPS TNFα remained elevated 12 h p.c..
Rectal temperature
In cows challenged with 10μg LPS the rectal temperature started to increase 4 h p.c.
in cows that received biopsies and 5 h p.c. in cows used only for milk sampling. The maximum was reached 6 h p.c. (40.8±0.1°C and 40.1±0.2°C, resp.). In these cows the rectal temperature decreased below 39°C 11 and 8 h p.c., resp.. In control cows and in cows that received other treatments the rectal temperature did not change and was between 37.7° C and 38.9° C throughout the entire experiment.
mRNA expression
TNFα. At 6 h p.c. the mRNA expression of TNFα (Table 2) (Table 2) .
IL-1β.
The mRNA expression of IL-1β ( Samples of quarters treated with 10µg LTA were for technical reasons not available.
Comparison of treatments with 0.2µg LPS and 20µg LTA (Figures 1 and 2 ) Figure 1A shows that a treatment of 0.2µg LPS and a treatment of 20µg LTA produced a near equivalent SCC response in milk that only varied with time to maximum. SCC started to increase at 3 h and 4 h p.c., resp., and reached the same level at 7 h p.c.. Between 4 and 6 h p.c. the LPS treatment induced higher SCC levels.
LDH activity in milk with LTA treatment was higher than in controls but lower than with LPS treatment at 4 h p.c. until the end of the experiment ( Figure 1B ).
TNFα in milk increased with LPS but did not result in a change with LTA treatment ( Figure 1C ). The overall response was based on SCC because this parameter is worldwide accepted as an indicator for mammary immune response.
The hourly measurements in this study showed that SCC started to increase approximately at the same time after challenge with all LPS and LTA dosages. The level of increase was, however, dose dependent. Others (Schröder et al., 2003; von Aulock et al., 2003) and this study showed that LTA required a higher dose than LPS to reach approximately a similar level of SCC increase.
The increase of mRNA expression of the measured immune factors was induced with lower dosages of LPS/LTA in milk cells than in mammary gland tissue. We believe that this may be the result of the teat canal application where LPS/LTA was being diluted by the milk that is produced before it reached the tissue where the biopsy was taken. The increased mRNA expression of cellular immune factors 6 h p.c. declined at 12 h p.c.. This is due to the loss of cellular viability and immune capacity that occurs within a few hours (Baumert et al., 2009) Our report of the systemic clinical sign shown by the increase of the rectal temperature with higher dosages of LPS is consistent with earlier investigations (Schmitz et al., 2004) . However, with our LTA treatments, there was no increase of rectal temperature. This may be explained by the lack of TNFα induction in response to LTA in these dosages described by Riollet et al., (2000) and Bannerman et al., (2004) and supported by our demonstration of no TNFα milk appearance with LTA treatment.
The increase of LDH enzymatic activity in milk in response to LPS and LTA treatment in our experiment has been previously reported to occur during mastitis (Chagunda et al., 2006) . Although LDH in milk correlates with SCC (Hambitzer and Sommer, 1987) and the granulocytes and lymphocytes in milk are, besides the tissue, a source of LDH (Kato et al., 1989) we show that LTA produced a lower LDH increase compared to LPS when SCC appearance was equivalent. As LDH is an indication for cell damage and death (Glick, 1969) this can indicate an increased damage of mammary tissue. Such tissue damage could be one of the reasons for the higher severity of E.
coli mastitis when compared to S. aureus mastitis.
Cytokines and other pro-inflammatory factors that are produced after pathogen invasion or intramammary stimulation initiate and regulate the immune reaction (Rainard & Riollet, 2006) . TNFα serves as a rapidly responding central mediator of inflammatory functions and is known to increase in milk after LPS challenge (Paape et al., 2002) . Lactoferrin increases in milk during mastitis (Kawai et al., 1999) . The decrease of Lf mRNA expression in milk cells shown in our study has been previously reported for high SCC milk (Pfaffl et al., 2003) and after LPS stimulation (Wellnitz et al., 2010) .
This may reflect cellular damage or death. In mammary tissue the Lf mRNA expression was increased with LPS and LTA challenge. Although Kawai et al. (1999) found a higher Lf concentration in mastitis milk from cows infected with S. aureus than with E.
coli we show that there was no difference in mRNA expression increase in mammary tissue between LPS and LTA challenge when compared at a similar SCC increase. In the study of Kawai et al. (1999) no information about SCC is provided.
RANTES, a chemokine, was increased on mRNA level in milk cells and mammary tissue after LPS challenge, but not after LTA challenge. This supports previous findings where mRNA expression in mammary epithelial cells in vitro was higher when stimulated with heat inactivated E. coli compared to S. aureus in the same number (Griesbeck-Zilch et al., 2008) . This may contribute to lower cell recruitment into the mammary gland during S. aureus infection which can play a role in the mainly chronic development of this mastitis.
In conclusion, the initiation of a mammary immune response by LPS and LTA is dose-dependent. Milk cells respond to lower LPS and LTA dosages than mammary tissue, but this finding may be due to a dilution effect. LPS and LTA dosages that excite comparable SCC increases induce different immune responses in milk, milk cells and mammary tissue. This likely reflects the involvement of the mammary immune system in the different development of mastitis severity after the infection with different bacteria. And of course thanks to all, those were working in the stable, who looked after the cows during the experiments and who helped me even early in the morning.
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Lipopolysaccharide and lipoteichoic acid induce different immune responses in the bovine mammary gland
Emanuel Theodor Arnold
Mastitis is a common disease in dairy cows worldwide. Different pathogens, like Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) can be responsible for different clinical outcomes of mastitis infections, i.e. acute and severe or subclinical and chronic. The different mammary response to the pathogens could be related to these differences in the course of the disease. The innate immune system elicits the first response towards invading pathogens. The defense mechanism against pathogens relies on the appropriate expression of pathogen recognition receptors (PRRs) triggering the early release of effector molecules of the innate immune system. The PRRs recognize pathogen associated molecular patterns (PAMPs) towards specific cell wall components of different bacterial types. Major PAMPs that play a role in mastitis are the cell wall component lipopolysaccharide (LPS) of E. coli and other gram-negative bacteria and lipoteichoic acid (LTA) of S. aureus and other gram-positive bacteria. This study had the objective to determine if intramammary challenge with the endotoxins LPS from E. coli and LTA from S. aureus induce different immune responses in vivo with milk cells and mammary tissue. For the first time LPS and LTA were compared in the same experiment at dosages that induced a similar increase of somatic cell count (SCC) in the milk. Furthermore, the immune reaction of milk cells and the mammary tissue was compared. One udder quarter was challenged with different concentrations of LPS or LTA. From these quarters and from respective control quarters, milk samples and tissue biopsies were collected. SCC increased in all treatments in a dose-dependent manner and tumor necrosis factor-α concentrations in milk increased with all LPS dosages but not with LTA. Lactate dehydrogenase activity in milk increased dosedependently with all LPS and LTA treatments. mRNA expression of tumor necrosis factor-α, interleukin (IL)-1β, IL-8, lactoferrin, and RANTES showed dose-dependent responses in milk cells and mammary tissue. However, LPS was a stronger inducer of these factors than LTA at comparable SCC increases. The results show that LPS and LTA challenge of udder quarters with dosages that induce similar SCC increases stimulates the appearance of different immune factor patterns. This dissimilar response to LPS and LTA may partly explain the different course and intensity of acute or chronic mastitis after infection with E. coli and S. aureus, respectively. In the future this knowledge could be useful in dairy farming for the breeding of cows with a more effective immune system of the mammary gland against specific pathogens that are of high risk in inducing mastitis.
